Intraventricular Vancomycin Treatment for Shunt-related Ventriculitis Caused by Methicillin-resistant Staphylococcus Aureus in a Preterm Infant: A Case Report

Research output: Contribution to journalArticlepeer-review

Abstract

Posthemorragic hydrocephalus is a relatively common condition in prematures, often requiring ventriculoperitoneal shunts. We report a case of methicillin-resistant Staphylococcus aureus infection of a ventriculoperitoneal shunt in a premature neonate which failed conventional intravenous treatment. Despite the absence of published guidelines, we used available data and expert advice to treat the patient with intraventricular vancomycin. The treatment was successful in eradicating the infection without observed toxicity. This case highlights the need for international guidelines on intraventricular treatment for neonates.

Original languageEnglish
Pages (from-to)340-342
Number of pages3
JournalThe Pediatric infectious disease journal
Volume41
Issue number4
DOIs
Publication statusPublished - 1 Apr 2022

Bibliographical note

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Other keywords

  • Anti-Bacterial Agents/therapeutic use
  • Cerebral Ventriculitis/drug therapy
  • Encephalitis/drug therapy
  • Humans
  • Hydrocephalus/drug therapy
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Methicillin-Resistant Staphylococcus aureus
  • Myelitis
  • Vancomycin/therapeutic use
  • Ventriculoperitoneal Shunt/adverse effects
  • prematurity
  • ventriculitis vancomycin
  • ventriculoperitoneal shunt

Fingerprint

Dive into the research topics of 'Intraventricular Vancomycin Treatment for Shunt-related Ventriculitis Caused by Methicillin-resistant Staphylococcus Aureus in a Preterm Infant: A Case Report'. Together they form a unique fingerprint.

Cite this